OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Novavax NVX-COV2373 triggers potent neutralization of Omicron sub-lineages
Jinal N. Bhiman, Simone I. Richardson, Bronwen E. Lambson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 14
Jinal N. Bhiman, Simone I. Richardson, Bronwen E. Lambson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 14
Showing 14 citing articles:
An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines
Fatemeh Bayani, Negin Safaei Hashkavaei, Sareh Arjmand, et al.
Progress in Biophysics and Molecular Biology (2023) Vol. 178, pp. 32-49
Open Access | Times Cited: 43
Fatemeh Bayani, Negin Safaei Hashkavaei, Sareh Arjmand, et al.
Progress in Biophysics and Molecular Biology (2023) Vol. 178, pp. 32-49
Open Access | Times Cited: 43
Application of Traditional Vaccine Development Strategies to SARS-CoV-2
Halie M. Rando, Ronan Lordan, Alexandra Lee, et al.
mSystems (2023) Vol. 8, Iss. 2
Open Access | Times Cited: 14
Halie M. Rando, Ronan Lordan, Alexandra Lee, et al.
mSystems (2023) Vol. 8, Iss. 2
Open Access | Times Cited: 14
The Epidemiological Features of the SARS-CoV-2 Omicron Subvariant BA.5 and Its Evasion of the Neutralizing Activity of Vaccination and Prior Infection
Dandan Tian, Wenjian Nie, Yanhong Sun, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1699-1699
Open Access | Times Cited: 17
Dandan Tian, Wenjian Nie, Yanhong Sun, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1699-1699
Open Access | Times Cited: 17
Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (CovovaxTM) after homologous and heterologous two-dose regimens
Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, et al.
International Journal of Infectious Diseases (2022) Vol. 126, pp. 64-72
Open Access | Times Cited: 15
Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, et al.
International Journal of Infectious Diseases (2022) Vol. 126, pp. 64-72
Open Access | Times Cited: 15
Efficacy and Safety of COVID-19 Vaccines—An Update
Eshani Sharma, Sraddha Revinipati, Saisha Bhandari, et al.
Diseases (2022) Vol. 10, Iss. 4, pp. 112-112
Open Access | Times Cited: 15
Eshani Sharma, Sraddha Revinipati, Saisha Bhandari, et al.
Diseases (2022) Vol. 10, Iss. 4, pp. 112-112
Open Access | Times Cited: 15
Nanograms of SARS-CoV-2 spike protein delivered by exosomes induce potent neutralization of both delta and omicron variants
Mafalda Cacciottolo, Yujia Li, Justin B Nice, et al.
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0290046-e0290046
Open Access | Times Cited: 7
Mafalda Cacciottolo, Yujia Li, Justin B Nice, et al.
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0290046-e0290046
Open Access | Times Cited: 7
An overview of protein-based SARS-CoV-2 vaccines
Yogesh R. Suryawanshi
Vaccine (2023) Vol. 41, Iss. 42, pp. 6174-6193
Closed Access | Times Cited: 6
Yogesh R. Suryawanshi
Vaccine (2023) Vol. 41, Iss. 42, pp. 6174-6193
Closed Access | Times Cited: 6
Nanograms of SARS-CoV-2 Spike Protein Delivered by Exosomes Induce Potent Neutralization of Both Delta and Omicron Variants
Mafalda Cacciottolo, Yujia Li, Justin B Nice, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Mafalda Cacciottolo, Yujia Li, Justin B Nice, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection
Sabina Vohra-Miller, Ilan S. Schwartz
Canadian Medical Association Journal (2022) Vol. 194, Iss. 35, pp. E1214-E1214
Open Access | Times Cited: 8
Sabina Vohra-Miller, Ilan S. Schwartz
Canadian Medical Association Journal (2022) Vol. 194, Iss. 35, pp. E1214-E1214
Open Access | Times Cited: 8
<strong>Efficacy of COVID-19 Vaccines Against the Omicron Variant of SARS-CoV-2</strong>
Kritika Srinivasan Rajsri, Meena Singh, Mana Rao
(2023)
Open Access | Times Cited: 1
Kritika Srinivasan Rajsri, Meena Singh, Mana Rao
(2023)
Open Access | Times Cited: 1
UB-612 Multitope Vaccine Targeting SARS-CoV-2 Spike and Non-Spike Proteins Provides Broad and Durable Immune Responses
Chang Yi Wang, Wen‐Jiun Peng, Be-Sheng Kuo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Chang Yi Wang, Wen‐Jiun Peng, Be-Sheng Kuo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (Covovax™) after homologous and heterologous two-dose regimens
Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Neutralization of SARS-CoV-2 Omicron BA.4/BA.5 subvariant by a booster dose of bivalent adjuvanted subunit vaccine containing Omicron BA.4/BA.5 and BA.1 subvariants
Tsun‐Yung Kuo, Chia-En Lien, Yi‐Jiun Lin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Tsun‐Yung Kuo, Chia-En Lien, Yi‐Jiun Lin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
NVX-CoV2373, un vaccin à sous-unités protéiques contre l’infection au SRAS-CoV-2
Sabina Vohra-Miller, Ilan S. Schwartz
Canadian Medical Association Journal (2022) Vol. 194, Iss. 45, pp. E1554-E1555
Open Access
Sabina Vohra-Miller, Ilan S. Schwartz
Canadian Medical Association Journal (2022) Vol. 194, Iss. 45, pp. E1554-E1555
Open Access
